Hyperosmia and Depression Following Exposure to Toxic Vapors
JAMA 264:2803, Silverman,J.S.&Henkin,R.I., 1993
Herpes Simplex & the Human Nervous System
Milit Med 140:765, Finelli,P.F., 1975
Clinicopathologic Conference, Diffuse Large B-Cell Lymphoma
NEJM 386:977-986, Case 7-2022, 2022
Precipitous Deterioration of Motor Function, Cognition, and Behavior
JAMA Neurol 74:591-596, Fernandez-Fournier, M.,et al, 2017
Migraine
NEJM 377:553-561, Charles, A., 2017
Neuropsychiatric Involvement of Behcets Disease
www.SMGEbooks.com Dec, Soyak, M., 2017
Deep-Brain Stimulation - Entering the Era of Human Neural-Network Modulation
NEJM 371:1369-1373, Okun, M.S., 2014
MELAS
MedLink.com, August, Klopstock, T., 2012
Clinicopath Conf, Intravascular Large-B-Cell Lympoma
NEJM 362:1129-1138, Case 9-2010, 2010
Clinicopath Conf., Progressive Multifocal Leukoencephalopathy
NEJM 362:1431-1437, Case 11-2010, 2010
The Writing on the Wall
Lancet 372:344, Wilder-Smith,E.P. &Ng,E.S., 2008
Effect on Mood of Subthalamic DBS for Parkinson's Disease
Neurol 59:1427-1429, Berney,A.,et al, 2002
Serotonin Sydrome
Medicine 79:201-209, Mason,P.J. et al, 2000
Transient Acute Depression Induced by High-Frequency Deep-Brain Stimulation
NEJM 340:1476-1480,1500, Bejjani,B-P.,et al, 1999
Transient Acute Depression Induced by High-Frequency Deep-Brain Stimulation
NEJM 341:1003-1004, Bezerra,M.L.S.,et al, 1999
Multiple Sclerosis, Side Effects of Interferon Beta Therapy and Their Management
Neurol 53:1622-1627, Walther,E.U.&Hohlfeld,R., 1999
Opsoclonus as a Dominant Sign in Primary Sjogrens Syndrome
Neuro-Opthlhal 22:135-138, Lubec,D.,et al, 1999
A 36-Year-Old Woman Recuperating From a Stroke
JAMA 277:1970-1976, Alexander,M., 1997
Clinicopath Conf
Progressive Supranuclear Palsy, Case 26, 1997, NEJM 337:549-55697., , 1997
Side Effect Profile of Interferon Beta-1b in MS:Results of an Open Label Trial
Neurol 46:552-554, Neilley,L.K.,et al, 1996
Parkinson's Disease
JNNP 57:672-681, Marsden,C.D., 1994
Acromegaly:Clinical and Biochemical Features in 500 Patients
Medicine 73:233-240, Ezzat,S.,et al, 1994
Side Effects of Glucocorticoid Treatment, Experience of the Optic Neuritis Treatment Trial
JAMA 269:2110-2112, Chrousos,G.A.,et al, 1993
Nervous System Lyme Borreliosis-Revisited
Arch Neurol 49:102-107, Finkel,M.J.&Halperin,J.J., 1992
Complications of Acute Stroke
Lancet 339:721-724, Oppenheimer,S.&Hachinski,V., 1992
Neurologic Syndrome in 25 Workers from an Aluminim Smelting Plant
Arch Int Med 152:1443-1448, White,D.M.,et al, 1992
Extrapyramidal side Effects of Antiemetics Presenting as Psychiatric Illness
Gen Hosp Psychiatry 14:192-195, Rodgers,C., 1992
Neurologic Manifestations of Giant Cell Arteritis
Am J Med 89:67-72, Reich,K.A.,et al, 1990
Chronic Neurologic Manifestations of Lyme Disease
NEJM 323:1438-1444, Logigian,E.L.,et al, 1990
A Simple Procedure for General Screening for Functional Disability in Elderly Patients
Ann Int Med 112:699-706, Lachs,M.S.,et al, 1990
The Chronic Fatigue Syndrome-One Entity or Many?
NEJM 319:1726-1728, Swartz,M.N., 1989
Parkinsonism, Tremor, and Depression Induced by Cinnarizine and Flunarizine
BMJ 297:722-723, Capella,D.,et al, 1988
The Reversible Dementias:Do They Reverse?
Ann Int Med 109:476-486, Clarfield,A.M., 1988
Flunarizine- & -Cinnarizine-Induced Extrapyramidal Reactions
Neurol 37:881-884, Micheli,F.,et al, 1987
Parkinsonism, Tardive Dyskinesia, Akathisia, & Depression Induced by Flunarizine
Lancet 1:1303-1304, Chouza,C.,et al, 1986
Increased Antidepressant Use in Patients Prescribed B-Blockers
JAMA 255:357-360, Avorn,J.,et al, 1986
Nortriptyline Treatment of Post-Stroke Depression:A Double-Blind Study
Lancet 1:298-300, Lipsey,J.R.,et al, 1984
Dementia Induced by Methyldopa with Haloperidol
NEJM 295:1222, Thorton,W.E., 1976
Case Records of the MassGeneral Hospital, Case 41-1975, Acute Intermittent Porphyria
NEJM 293:817, Woods,B., 1975